Endometrial cancer risk and survival by tumor MMR status.
Christina M NagleTracy A O'MaraYen TanDaniel D BuchananAndreas ObermairPenny BlomfieldMichael A QuinnPenelope M WebbAmanda B Spurdlenull nullPublished in: Journal of gynecologic oncology (2018)
The risk of EC is not associated with MMR status. Accurate separation of germline from somatic causes of MMR deficiency suggests that patients with endometrioid subtype somatic MMR-deficient tumors have poorer EC-specific survival than those with MMR-proficient tumors, after accounting for other prognostic factors.